Singapore: A Main Driver in Research and Development for Pharmaceuticals
Singapore is the world 12th largest pharmaceuticals producer, and over 30 drug producers have a research and development presence in Singapore including Novartis, Eli Lilly, Takeda and GSK. Singapore has a highly developed physical and regulatory infrastructure, skilled manpower and easy access to rapidly expanding Asian markets. Although pharmaceutical companies may be dealing with a sluggish economic growth in Singapore, Euromonitor expects the country to remain a leading mediator between western companies and growing Asian markets.
Watch on YouTube